Thanks to @AISHealth & Leslie Small for covering last week’s #InflationReductionAct anniversary. Reflecting on the IRA, Ceci Connolly said, “Potentially the most significant health care provision in that act was the extension of the enhanced subsidies for working Americans to

New (ish) from me:

Will an upcoming Supreme Court ruling reshape how health care is regulated? Attorneys Richard Hughes IV and Will Walters discuss the Chevron deference, in @AISHealth Leslie Small [Excerpt and links.] #SCOTUS #HealthCare bit.ly/40atcbl

The FTC's Lina Khan seeing that health insurers are trying to buy each other again:

My entry into the sea of articles on how Wegovy's cardiac indication will influence insurance coverage. But it contains a unique insight from a source: MA-PDs (that's private Medicare plans with rx drug coverage) are more likely to cover Wegovy than stand-alone Part D plans.

Nothing perfectly encapsulates the #healthplan industry but —

My story from Tuesday's House Oversight Cmte hearing featuring 3 PBM execs, focusing on what they did (and didn't) say about their shadowy, largely foreign-operated group purchasing orgs: aishealth.mmitnetwork.com/blogs/radar-on…

New from me: UnitedHealth's PBM Optum Rx in 2025 is not only stopping coverage of Humira for some employer plan members, it's also co-preferring a Stelara biosimilar alongside the reference drug. And its private label drug distributor plays a big role: aishealth.mmitnetwork.com/blogs/radar-on…

This is an interesting look at the path large companies are navigating on PBM reform from our @AISHealth colleagues ... Pink Sheet, Citeline Regulatory #pinksheet #Pharma: Death of a PBM Reform Bill: Why Big Employers Helped Scuttle California’s SB 966 insights.citeline.com//pink-sheet/ma…